CRISPR patent fight takes a surprise turn
The fight over coveted CRISPR patents has for years been a familiar tussle between the University of California and the Broad Institute of MIT and Harvard. It's about to get more complicated.
In a startling turn of events, MilliporeSigma, a unit of Germany-based Merck KGaA, has asked the U.S. Patent and Trademark office to open an interference proceeding between CRISPR-Cas9 patents that it applied for back in 2012 as well as patents that the University of California has applied for or been award, STAT’s Sharon Begley reports in an exclusive story this morning.
In a startling turn of events, MilliporeSigma, a unit of Germany-based Merck KGaA, has asked the U.S. Patent and Trademark office to open an interference proceeding between CRISPR-Cas9 patents that it applied for back in 2012 as well as patents that the University of California has applied for or been award, STAT’s Sharon Begley reports in an exclusive story this morning.
The petition’s aim is to “highlight a fundamental unfairness” in how the company’s CRISPR patent applications “are being compared to others,” company attorney Benjamin Sodey told STAT.
.png)
No hay comentarios:
Publicar un comentario